GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
73.83 USD
+0.65 (+0.89%)
At close:
73.83 USD
0 (0%)
After Hours:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- GEHC had positive earnings in the past year.
- In the past year GEHC had a positive cash flow from operations.
- Each year in the past 5 years GEHC has been profitable.
- In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 5.65%, GEHC belongs to the best of the industry, outperforming 81.38% of the companies in the same industry.
- GEHC has a better Return On Equity (20.09%) than 94.15% of its industry peers.
- GEHC has a Return On Invested Capital of 7.81%. This is amongst the best in the industry. GEHC outperforms 81.91% of its industry peers.
- GEHC had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- GEHC has a better Profit Margin (10.11%) than 82.98% of its industry peers.
- GEHC's Profit Margin has declined in the last couple of years.
- GEHC has a Operating Margin of 13.40%. This is amongst the best in the industry. GEHC outperforms 81.38% of its industry peers.
- GEHC's Operating Margin has declined in the last couple of years.
- The Gross Margin of GEHC (39.98%) is worse than 67.02% of its industry peers.
- In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GEHC is still creating some value.
- GEHC has less shares outstanding than it did 1 year ago.
- GEHC has more shares outstanding than it did 5 years ago.
- GEHC has about the same debt/assets ratio as last year.
2.2 Solvency
- GEHC has an Altman-Z score of 1.87. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.87, GEHC is in line with its industry, outperforming 57.98% of the companies in the same industry.
- The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
- GEHC has a better Debt to FCF ratio (6.67) than 73.40% of its industry peers.
- A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
- GEHC has a Debt to Equity ratio of 0.92. This is in the lower half of the industry: GEHC underperforms 76.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.87 |
ROIC/WACC0.99
WACC7.93%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that GEHC should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.37, GEHC is doing worse than 81.91% of the companies in the same industry.
- A Quick Ratio of 1.13 indicates that GEHC should not have too much problems paying its short term obligations.
- GEHC has a worse Quick ratio (1.13) than 77.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 2.00% over the past year.
- The earnings per share for GEHC have been decreasing by -31.63% on average. This is quite bad
- Looking at the last year, GEHC shows a small growth in Revenue. The Revenue has grown by 4.85% in the last year.
- GEHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.74% yearly.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
3.2 Future
- The Earnings Per Share is expected to grow by 8.20% on average over the next years. This is quite good.
- Based on estimates for the next years, GEHC will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.12 indicates a correct valuation of GEHC.
- Compared to the rest of the industry, the Price/Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 86.17% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.18. GEHC is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 14.29, the valuation of GEHC can be described as correct.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 89.36% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, GEHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.12 | ||
| Fwd PE | 14.29 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaper than 87.23% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 86.17% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.38 | ||
| EV/EBITDA | 11.66 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y11.38%
EPS Next 3Y11.08%
5. GEHC Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.19%, GEHC is not a good candidate for dividend investing.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.24. GEHC pays more dividend than 89.36% of the companies in the same industry.
- With a Dividend Yield of 0.19, GEHC pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
- GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
GEHC Fundamentals: All Metrics, Ratios and Statistics
73.83
+0.65 (+0.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners93.2%
Inst Owner Change-7.81%
Ins Owners0.35%
Ins Owner Change0.63%
Market Cap33.69B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target94.99 (28.66%)
Short Float %2.43%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.31%
PT rev (3m)3.8%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)4.38%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)3.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.12 | ||
| Fwd PE | 14.29 | ||
| P/S | 1.63 | ||
| P/FCF | 22.38 | ||
| P/OCF | 16.95 | ||
| P/B | 3.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.66 |
EPS(TTM)4.58
EY6.2%
EPS(NY)5.17
Fwd EY7%
FCF(TTM)3.3
FCFY4.47%
OCF(TTM)4.35
OCFY5.9%
SpS45.2
BVpS22.75
TBVpS-9.29
PEG (NY)1.26
PEG (5Y)N/A
Graham Number48.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.87 |
F-Score4
WACC7.93%
ROIC/WACC0.99
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.17%
EBIT Next 3Y14.85%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
Can you provide the profitability details for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 16.12 and the Price/Book (PB) ratio is 3.25.
What is the earnings growth outlook for GE HEALTHCARE TECHNOLOGY?
The Earnings per Share (EPS) of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 12.83% in the next year.